Cereno Scientific AB (OSTO:CRNO B) Operating Cash Flow per Share : kr-0.37 (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Cereno Scientific AB Operating Cash Flow per Share?

Cereno Scientific AB's operating cash flow per share for the three months ended in Mar. 2025 was kr-0.08. Cereno Scientific AB's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was kr-0.37.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -43.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -48.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Cereno Scientific AB's Operating Cash Flow per Share or its related term are showing as below:

OSTO:CRNO B' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -92.2 Med: 14.4 Max: 66.1
Current: -43.2

During the past 10 years, Cereno Scientific AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 66.10% per year. The lowest was -92.20% per year. And the median was 14.40% per year.

OSTO:CRNO B's 3-Year OCF Growth Rate is ranked worse than
92.69% of 780 companies
in the Drug Manufacturers industry
Industry Median: 8.85 vs OSTO:CRNO B: -43.20

Cereno Scientific AB Operating Cash Flow per Share Historical Data

The historical data trend for Cereno Scientific AB's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cereno Scientific AB Operating Cash Flow per Share Chart

Cereno Scientific AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.23

-0.13

-0.14

-0.16

-0.37

Cereno Scientific AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.07	-0.04	-0.11	-0.15	-0.08

Competitive Comparison of Cereno Scientific AB's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Cereno Scientific AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cereno Scientific AB's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cereno Scientific AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cereno Scientific AB's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Cereno Scientific AB Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Cereno Scientific AB's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-103.422	/	281.702
	=	-0.37

Cereno Scientific AB's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-24.426	/	309.159
	=	-0.08

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.37

Cereno Scientific AB Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Cereno Scientific AB's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cereno Scientific AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (OSTO:CRNO B) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

4A1:Germany

Address

BioVentureHub, Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.cerenoscientific.se

Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.

Cereno Scientific AB Headlines

No Headlines